Ylanan, Jessa .
HRN: 24-78-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/05/2024
CEFUROXIME 750MG (VIAL)
04/05/2024
04/12/2024
IV
750mg
Q8h
PCAP Non Severe
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes